Identification of relapse predictors in IgG4-related disease using multivariate analysis of clinical data at the first visit and initial treatment

Rheumatology (United Kingdom)

Volumn 54, Issue 1, 2014, Pages 45-49

  Yamamoto, Motohisa ^a   Nojima, Masanori ^b   Takahashi, Hiroki ^a   Yokoyama, Yoshihiro ^a   Ishigami, Keisuke ^a   Yajima, Hidetaka ^a   Shimizu, Yui ^a   Tabeya, Tetsuya ^a   Matsui, Mikiko ^a   Suzuki, Chisako ^a   Naishiro, Yasuyoshi ^a   Takano, Ken ichi ^a   Himi, Tetsuo ^a   Imai, Kohzoh ^b   Shinomura, Yasuhisa ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Autoimmune pancreatitis; IgG4 related disease; Mikulicz's disease; Multivariate analysis; Relapse

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G4; PREDNISOLONE;

ADULT; ARTICLE; AUTOIMMUNE PANCREATITIS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE DURATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; EOSINOPHIL COUNT; FEMALE; FOLLOW UP; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN G4 RELATED DISEASE; MAJOR CLINICAL STUDY; MALE; MIKULICZ DISEASE; MULTIVARIATE ANALYSIS; ONSET AGE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; RELAPSE;

EID: 84928748237     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keu228     Document Type: Article

References (10)

1. Yamamoto M, Takahashi H, Shinomura Y. Mechanisms and assessment of IgG4-related disease: lessons for the rheumatologist. Nat Rev Rheumatol 2014;10: 148-59.
2. Shimizu Y, Yamamoto M, Naishiro Y et al. Necessity of early intervention for IgG4-related disease-delayed treatment induces fibrosis progression. Rheumatology 2013;52:679-83.
3. Yamamoto M, Harada S, Ohara M et al. Beneficial effects of steroid therapy for Mikulicz's disease. Rheumatology 2005;44:1322-3.
4. Khosroshahi A, Stone JH. Treatment approaches to IgG4-related systemic disease. Curr Opin Rheumatol 2011;23: 67-71.
5. Yamamoto M, Takahashi H, Ishigami K et al. Relapse patterns in IgG4-related disease. Ann Rheum Dis 2012;71: 1755.
6. Gilmore W, Weiner LP, Correale J. Effect of estradiol on cytokine secretion by proteolipid protein-specific T cells clones isolated from multiple sclerosis patients and normal control subjects. J Immunol 1997;158: 446-51.
7. Piccini MP, Giudizi MG, Biagiotti R et al. Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J Immunol 1995;155:128-33.
8. Araneo BA, Dowell T, Diegel M, Daynes RA. Dihydrotestosterone exerts a depressive influence on the production of interleukin-4 (IL-4), IL-5, and gamma-interferon, but not IL-2 by activated murine T cells. Blood 1991;78: 688-99.
9. Tanaka A, Moriyama M, Nakashima H et al. Th2 and regulatory immune reactions contribute to IgG4 production and the initiation of Mikulicz's disease. Arthritis Rheum 2012;64:254-63.
10. Kamisawa T, Okazaki K, Kawa S et al. Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP. J Gastroenterol 2010;45: 471-7.